Liminal BioSciences Ownership 2024 | Who Owns Liminal BioSciences Now?


OverviewRevenueFinancialsChart

Institutional Ownership

0.00%

Insider Ownership

61.26%

Institutional Holders

2.00

Liminal BioSciences Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SUSQUEHANNA INTERNATIONAL GROUP, LLP4.55%-14,13314,133100.00%53,705,000Mar 31, 2023
NATIONAL BANK OF CANADA /FI/3.17%0.00%9,8539,853100.00%34,191,000Mar 31, 2023
ESTABROOK CAPITAL MANAGEMENT0.16%0.00%500500100.00%1,900,000Mar 31, 2023
ROYAL BANK OF CANADA0.15%-475475100.00%2,000,000Mar 31, 2023
UBS GROUP AG0.02%-4848100.00%182,000Mar 31, 2023
IFP ADVISORS, INC----1-100.00%-Mar 31, 2023
GROUP ONE TRADING, L.P.----10-100.00%-Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC----3,850-100.00%-Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----2,274-100.00%-Mar 31, 2023
MILLENNIUM MANAGEMENT LLC----1,135-100.00%-Mar 31, 2023
NATIONAL BANK OF CANADA /FI/----9,869-100.00%-Mar 31, 2023
ESTABROOK CAPITAL MANAGEMENT----500-100.00%-Mar 31, 2023
MORGAN STANLEY----7-100.00%-Mar 31, 2023
UBS GROUP AG----244-100.00%-Mar 31, 2023
ROYAL BANK OF CANADA----486-100.00%-Mar 31, 2023

Liminal BioSciences's largest institutional shareholder is SUSQUEHANNA INTERNATIONAL GROUP, LLP, holding 4.55% of the company's total share outstanding, currently valued at $53.70M. The top 10 institutional shareholders own together 8.06% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ESTABROOK CAPITAL MANAGEMENT0.16%0.00%500500100.00%1,900,000Mar 31, 2023
NATIONAL BANK OF CANADA /FI/3.17%0.00%9,8539,853100.00%34,191,000Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP4.55%-14,13314,133100.00%53,705,000Mar 31, 2023
ROYAL BANK OF CANADA0.15%-475475100.00%2,000,000Mar 31, 2023
UBS GROUP AG0.02%-4848100.00%182,000Mar 31, 2023
IFP ADVISORS, INC----1-100.00%-Mar 31, 2023
GROUP ONE TRADING, L.P.----10-100.00%-Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC----3,850-100.00%-Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----2,274-100.00%-Mar 31, 2023
MILLENNIUM MANAGEMENT LLC----1,135-100.00%-Mar 31, 2023
NATIONAL BANK OF CANADA /FI/----9,869-100.00%-Mar 31, 2023
ESTABROOK CAPITAL MANAGEMENT----500-100.00%-Mar 31, 2023
MORGAN STANLEY----7-100.00%-Mar 31, 2023
UBS GROUP AG----244-100.00%-Mar 31, 2023
ROYAL BANK OF CANADA----486-100.00%-Mar 31, 2023

The largest Liminal BioSciences shareholder by % of total assets is ESTABROOK CAPITAL MANAGEMENT. The company owns 500.00 shares of Liminal BioSciences (LMNL), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SUSQUEHANNA INTERNATIONAL GROUP, LLP4.55%-14,13314,133100.00%53,705,000Mar 31, 2023
NATIONAL BANK OF CANADA /FI/3.17%0.00%9,8539,853100.00%34,191,000Mar 31, 2023
ESTABROOK CAPITAL MANAGEMENT0.16%0.00%500500100.00%1,900,000Mar 31, 2023
ROYAL BANK OF CANADA0.15%-475475100.00%2,000,000Mar 31, 2023
UBS GROUP AG0.02%-4848100.00%182,000Mar 31, 2023
IFP ADVISORS, INC----1-100.00%-Mar 31, 2023
MORGAN STANLEY----7-100.00%-Mar 31, 2023
GROUP ONE TRADING, L.P.----10-100.00%-Mar 31, 2023
UBS GROUP AG----244-100.00%-Mar 31, 2023
ROYAL BANK OF CANADA----486-100.00%-Mar 31, 2023
ESTABROOK CAPITAL MANAGEMENT----500-100.00%-Mar 31, 2023
MILLENNIUM MANAGEMENT LLC----1,135-100.00%-Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----2,274-100.00%-Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC----3,850-100.00%-Mar 31, 2023
NATIONAL BANK OF CANADA /FI/----9,869-100.00%-Mar 31, 2023

As of Mar 31 2023, Liminal BioSciences's largest institutional buyer is SUSQUEHANNA INTERNATIONAL GROUP, LLP. The company purchased 14.13K stocks of LMNL, valued at $53.70M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NATIONAL BANK OF CANADA /FI/----9,869-100.00%-Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC----3,850-100.00%-Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----2,274-100.00%-Mar 31, 2023
MILLENNIUM MANAGEMENT LLC----1,135-100.00%-Mar 31, 2023
ESTABROOK CAPITAL MANAGEMENT----500-100.00%-Mar 31, 2023
ROYAL BANK OF CANADA----486-100.00%-Mar 31, 2023
UBS GROUP AG----244-100.00%-Mar 31, 2023
GROUP ONE TRADING, L.P.----10-100.00%-Mar 31, 2023
MORGAN STANLEY----7-100.00%-Mar 31, 2023
IFP ADVISORS, INC----1-100.00%-Mar 31, 2023
UBS GROUP AG0.02%-4848100.00%182,000Mar 31, 2023
ROYAL BANK OF CANADA0.15%-475475100.00%2,000,000Mar 31, 2023
ESTABROOK CAPITAL MANAGEMENT0.16%0.00%500500100.00%1,900,000Mar 31, 2023
NATIONAL BANK OF CANADA /FI/3.17%0.00%9,8539,853100.00%34,191,000Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP4.55%-14,13314,133100.00%53,705,000Mar 31, 2023

As of Mar 31 2023, Liminal BioSciences's biggest institutional seller is NATIONAL BANK OF CANADA /FI/. The company sold -9.87K shares of LMNL, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SUSQUEHANNA INTERNATIONAL GROUP, LLP4.55%-14,13314,133100.00%53,705,000Mar 31, 2023
NATIONAL BANK OF CANADA /FI/3.17%0.00%9,8539,853100.00%34,191,000Mar 31, 2023
ESTABROOK CAPITAL MANAGEMENT0.16%0.00%500500100.00%1,900,000Mar 31, 2023
ROYAL BANK OF CANADA0.15%-475475100.00%2,000,000Mar 31, 2023
UBS GROUP AG0.02%-4848100.00%182,000Mar 31, 2023

Liminal BioSciences's largest new institutional shareholder by number of shares is SUSQUEHANNA INTERNATIONAL GROUP, LLP, purchased 14.13K shares, valued at $53.70M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NATIONAL BANK OF CANADA /FI/----9,869-100.00%-Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC----3,850-100.00%-Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----2,274-100.00%-Mar 31, 2023
MILLENNIUM MANAGEMENT LLC----1,135-100.00%-Mar 31, 2023
ESTABROOK CAPITAL MANAGEMENT----500-100.00%-Mar 31, 2023
ROYAL BANK OF CANADA----486-100.00%-Mar 31, 2023
UBS GROUP AG----244-100.00%-Mar 31, 2023
GROUP ONE TRADING, L.P.----10-100.00%-Mar 31, 2023
MORGAN STANLEY----7-100.00%-Mar 31, 2023
IFP ADVISORS, INC----1-100.00%-Mar 31, 2023

Liminal BioSciences's largest sold out institutional shareholder by shares sold is NATIONAL BANK OF CANADA /FI/, sold -9.87K shares, valued at -, as of undefined.

Liminal BioSciences Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
FIDELITY CONCORD STREET TRUST0.00%22,737--Feb 29, 2024

Liminal BioSciences's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 22.74K shares, compromising 0.00% of its total assets.

Liminal BioSciences Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 232-85.71%
31 Dec, 221157.14%
30 Sep, 227-36.36%
30 Jun, 2211-8.33%
31 Mar, 22129.09%
31 Dec, 2111-8.33%
30 Sep, 2112-14.29%
30 Jun, 2114100.00%
31 Mar, 217-41.67%
31 Dec, 2012-
30 Sep, 201220.00%
30 Jun, 201025.00%
31 Mar, 208-11.11%
31 Dec, 199-

As of 31 Mar 23, 2 institutions are holding Liminal BioSciences's shares, representing a decrease of -85.71% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 231-100.00%
31 Dec, 22184,096-9.38%
30 Sep, 22203,153-24.97%
30 Jun, 22270,75526.01%
31 Mar, 22214,868-32.98%
31 Dec, 21320,622158.39%
30 Sep, 21124,085-1.50%
30 Jun, 21125,969207.14%
31 Mar, 2141,014-93.70%
31 Dec, 20650,993-79.51%
30 Sep, 203,177,753-5.83%
30 Jun, 203,374,3751.13%
31 Mar, 203,336,6850.58%
31 Dec, 193,317,279-

Liminal BioSciences (LMNL) has 1.00 shares outstanding as of 31 Mar 23, down -100.00% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 23--
31 Dec, 225.93%13.85%
30 Sep, 226.54%8.60%
30 Jun, 228.72%18.21%
31 Mar, 226.92%6.12%
31 Dec, 2110.63%61.91%
30 Sep, 214.14%23.41%
30 Jun, 214.21%224.24%
31 Mar, 211.37%0.19%
31 Dec, 2026.64%0.15%
30 Sep, 20134.70%0.65%
30 Jun, 20144.08%0.71%
31 Mar, 20142.68%0.33%
31 Dec, 19206.53%-

As of 31 Mar 23, Liminal BioSciences is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 31 Dec 22.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 23--100.00%
31 Dec, 225-
30 Sep, 22--100.00%
30 Jun, 222-66.67%
31 Mar, 226-25.00%
31 Dec, 218100.00%
30 Sep, 214-50.00%
30 Jun, 218300.00%
31 Mar, 212-66.67%
31 Dec, 206-
30 Sep, 206-
30 Jun, 20620.00%
31 Mar, 205-44.44%
31 Dec, 199-

- institutional shareholders have increased their position in LMNL stock as of 31 Mar 23 compared to 5 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 231-75.00%
31 Dec, 22350.00%
30 Sep, 222-50.00%
30 Jun, 22433.33%
31 Mar, 22350.00%
31 Dec, 212-33.33%
30 Sep, 21350.00%
30 Jun, 212-
31 Mar, 212-33.33%
31 Dec, 203-40.00%
30 Sep, 205400.00%
30 Jun, 201-
31 Mar, 201-
31 Dec, 19--

1 institutional shareholders have reduced their position in LMNL stock as of 31 Mar 23 compared to 3 in the previous quarter (a -75.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 232-85.71%1-100.00%----100.00%1-75.00%
31 Dec, 221157.14%184,096-9.38%5.93%13.85%5-350.00%
30 Sep, 227-36.36%203,153-24.97%6.54%8.60%--100.00%2-50.00%
30 Jun, 2211-8.33%270,75526.01%8.72%18.21%2-66.67%433.33%
31 Mar, 22129.09%214,868-32.98%6.92%6.12%6-25.00%350.00%
31 Dec, 2111-8.33%320,622158.39%10.63%61.91%8100.00%2-33.33%
30 Sep, 2112-14.29%124,085-1.50%4.14%23.41%4-50.00%350.00%
30 Jun, 2114100.00%125,969207.14%4.21%224.24%8300.00%2-
31 Mar, 217-41.67%41,014-93.70%1.37%0.19%2-66.67%2-33.33%
31 Dec, 2012-650,993-79.51%26.64%0.15%6-3-40.00%
30 Sep, 201220.00%3,177,753-5.83%134.70%0.65%6-5400.00%
30 Jun, 201025.00%3,374,3751.13%144.08%0.71%620.00%1-
31 Mar, 208-11.11%3,336,6850.58%142.68%0.33%5-44.44%1-
31 Dec, 199-3,317,279-206.53%-9---

Liminal BioSciences Peer Ownership


TickerCompany
EYENEyenovia, Inc.
RZLTRezolute, Inc.
TPSTTempest Therapeutics, Inc.
CYTCyteir Therapeutics, Inc.
XCURExicure, Inc.
XTLBXTL Biopharmaceuticals Ltd.
EWTXEdgewise Therapeutics, Inc.
PTIXProtagenic Therapeutics, Inc.
SNGXSoligenix, Inc.
ERASErasca, Inc.
KTTAPasithea Therapeutics Corp.
ERYPPHAXIAM Therapeutics S.A.
SPRBSpruce Biosciences, Inc.
FBRXForte Biosciences, Inc.
ATXIAvenue Therapeutics, Inc.
ADXNAddex Therapeutics Ltd
IMUXImmunic, Inc.
KZRKezar Life Sciences, Inc.

LMNL Ownership FAQ


Liminal BioSciences is owned by institutional shareholders (0%), insiders (61.26%), and public (0%). The largest institutional shareholder of Liminal BioSciences is SUSQUEHANNA INTERNATIONAL GROUP, LLP (4.55% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).

Liminal BioSciences's major institutional shareholders are SUSQUEHANNA INTERNATIONAL GROUP, LLP, NATIONAL BANK OF CANADA /FI/, ESTABROOK CAPITAL MANAGEMENT, ROYAL BANK OF CANADA, and UBS GROUP AG. The top five shareholders own together 8.06% of the company's share outstanding.

As of Mar 2023, there are 2 institutional shareholders of Liminal BioSciences.

SUSQUEHANNA INTERNATIONAL GROUP, LLP owns 14.13K shares of Liminal BioSciences, representing 4.55% of the company's total shares outstanding, valued at $53.7M (as of Mar 2023).

As of Mar 2023, NATIONAL BANK OF CANADA /FI/ holds 9.85K shares of Liminal BioSciences (LMNL), compromising 3.17% of the company, valued at $34.19M.

ESTABROOK CAPITAL MANAGEMENT is the third largest holder of Liminal BioSciences. The company owns 500 of the company's shares outstanding (worth $1.9M).